August 28, 2020
A key health ministry panel on August 27 cleared Kaken Pharmaceutical’s topical axillary hyperhidrosis treatment sofpironium bromide and Japan Tobacco’s renal anemia treatment enarodustat, setting the stage for their approval as early as next month along with other medicines on...read more